Amyloid antibody therapy for early-stage Alzheimer’s disease: a critical review of three recent trials
Crossref DOI link: https://doi.org/10.1007/s00415-024-12361-w
Published Online: 2024-04-13
Published Print: 2024-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Guiloff, A. E.
Rudge, P.
Text and Data Mining valid from 2024-04-13
Version of Record valid from 2024-04-13
Article History
Accepted: 24 March 2024
First Online: 13 April 2024
Declarations
:
: Both authors declare that they have no conflicts of interest and no disclosures.